Corrigendum: Regulatory T cells targeting a pathogenic MHC class II: insulin peptide epitope postpone spontaneous autoimmune diabetes.
Autor: | Obarorakpor N; Diabetes Center, Indiana Biosciences Research Institute, Indianapolis, IN, United States., Patel D; Diabetes Center, Indiana Biosciences Research Institute, Indianapolis, IN, United States., Boyarov R; Diabetes Center, Indiana Biosciences Research Institute, Indianapolis, IN, United States., Amarsaikhan N; Diabetes Center, Indiana Biosciences Research Institute, Indianapolis, IN, United States., Cepeda JR; Department of Medicine, Endocrinology, Diabetes & Metabolism, Baylor College of Medicine, Houston, TX, United States., Eastes D; Diabetes Center, Indiana Biosciences Research Institute, Indianapolis, IN, United States., Robertson S; Diabetes Center, Indiana Biosciences Research Institute, Indianapolis, IN, United States., Johnson T; Diabetes Center, Indiana Biosciences Research Institute, Indianapolis, IN, United States.; Department of Biostatistics and Health Data Science, School of Medicine, Indiana University, Indianapolis, IN, United States.; Melvin and Bren Simon Comprehensive Cancer Center, Experimental and Developmental Therapeutics, School of Medicine, Indiana University, Indianapolis, IN, United States.; Center for Computational Biology and Bioinformatics, School of Medicine, Indiana University, Indianapolis, IN, United States., Yang K; Herman B Wells Center for Pediatric Research and Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, United States.; School of Medicine, Indiana University Bloomington, Bloomington, IN, United States., Tang Q; Diabetes Center, University of California San Francisco, San Francisco, CA, United States.; Department of Surgery, University of California San Francisco, San Francisco, CA, United States.; Gladstone Institute of Genomic Immunology, University of California San Francisco, San Francisco, CA, United States., Zhang L; Diabetes Center, Indiana Biosciences Research Institute, Indianapolis, IN, United States.; Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN, United States.; Biochemistry & Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, United States. |
---|---|
Jazyk: | angličtina |
Zdroj: | Frontiers in immunology [Front Immunol] 2024 Mar 07; Vol. 15, pp. 1391518. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024). |
DOI: | 10.3389/fimmu.2024.1391518 |
Abstrakt: | [This corrects the article DOI: 10.3389/fimmu.2023.1207108.]. (Copyright © 2024 Obarorakpor, Patel, Boyarov, Amarsaikhan, Cepeda, Eastes, Robertson, Johnson, Yang, Tang and Zhang.) |
Databáze: | MEDLINE |
Externí odkaz: |